Personal information

No personal information available

Activities

Works (9)

Caregivers’ Perspectives on the Impact of Cannabidiol (CBD) Treatment for Dravet and Lennox-Gastaut Syndromes: A Multinational Qualitative Study

Journal of Child Neurology
2023-05 | Journal article
Part of ISSN: 1708-8283
Contributors: Jade Marshall; Hanna Skrobanski; Lisa Moore-Ramdin; Klaudia Kornalska; Paul Swinburn; Boudewijn Gunning
Source: Self-asserted source
Jade Marshall via Crossref Metadata Search

Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex

PharmacoEconomics - Open
2022-01 | Journal article
Contributors: Siu Hing Lo; Jade Marshall; Hanna Skrobanski; Andrew Lloyd
Source: check_circle
Crossref

Impact of developmental and epileptic encephalopathies on caregivers: A literature review

Epilepsy & Behavior
2021-11 | Journal article
Contributors: Katy Gallop; Andrew J. Lloyd; Jennifer Olt; Jade Marshall
Source: check_circle
Crossref

Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome

Clinical Therapeutics
2021-11 | Journal article
Contributors: Siu Hing Lo; Andrew Lloyd; Jade Marshall; Kishan Vyas
Source: check_circle
Crossref

Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”

PharmacoEconomics
2021-04 | Journal article
Contributors: Kelly Hollenack; Jade Marshall
Source: check_circle
Crossref

Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal

Advances in Therapy
2020-02 | Journal article
Part of ISSN: 0741-238X
Part of ISSN: 1865-8652
Source: Self-asserted source
Jade Marshall

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis

Journal of Managed Care & Specialty Pharmacy
2017-03 | Journal article
Part of ISSN: 2376-0540
Part of ISSN: 2376-1032
Source: Self-asserted source
Jade Marshall

Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)

1.5 Diffuse Parenchymal Lung Disease
2016-09 | Conference abstract
Source: Self-asserted source
Jade Marshall

M272 Estimated Cost And Payment By Results (pbr) Tariff Reimbursement For Idiopathic Pulmonary Fibrosis Services Across 14 Specialist Providers In England

Thorax
2014-12-01 | Journal article
Part of ISSN: 0040-6376
Source: Self-asserted source
Jade Marshall